The use of reamberin in combined intensive care of acute poisoning
| Autor: | Bair V. Batotsyrenov, Glushkov Si, Loladze At, A. L. Kovalenko, A. N. Lodyagin, Livanov Ga |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Antioxidant
business.industry medicine.medical_treatment General Medicine Acute toxicity Lipid peroxidation 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine chemistry 030220 oncology & carcinogenesis Anesthesia Intensive care Intensive therapy Medicine Hypoxic brain Tissue hypoxia 030211 gastroenterology & hepatology In patient business |
| Zdroj: | Clinical Medicine (Russian Journal). 94:339-346 |
| ISSN: | 2412-1339 0023-2149 |
| DOI: | 10.18821/0023-2149-2016-94-5-339-346 |
| Popis: | This review is focused on the substrate antihypoxant reamberin used in intensive therapy of acute poisoning with special reference to the mechanisms of its action consisting in the reduction of the severity of metabolic disorders manifested as a decrease of tissue hypoxia, recovery of antioxidant defense and suppression of the activity of lipid peroxidation and endotoxicosis. The antihyhypoxant activity of reamberin is apparent as the reduction of the hypoxic brain lesions in patients with acute poisoning which leads to a significant improvement in the clinical course of acute poisoning and decreases the number of adverse outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|